Fidelity Advisor Freedom 2020 Fund - Class A
FDAFX
NASDAQ
| Weiss Ratings | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Fidelity Investments | |||
| Manager/Tenure (Years) | Andrew J Dierdorf (15), Brett F. Sumsion (12), Cait Dourney Earle (1), 1 other | |||
| Website | http://www.institutional.fidelity.com | |||
| Fund Information | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Fidelity Advisor Freedom 2020 Fund - Class A | |||
| Category | Target-Date 2020 | |||
| Sub-Category | Target Date | |||
| Prospectus Objective | Asset Allocation | |||
| Inception Date | Jul 24, 2003 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.19% | |||
| Dividend | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.65% | |||
| Asset Allocation | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | -0.22% | |||
| Stock | 46.95% | |||
| U.S. Stock | 23.90% | |||
| Non-U.S. Stock | 23.05% | |||
| Bond | 52.95% | |||
| U.S. Bond | 46.34% | |||
| Non-U.S. Bond | 6.61% | |||
| Preferred | 0.05% | |||
| Convertible | 0.01% | |||
| Other Net | 0.25% | |||
| Price History | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.39% | |||
| 30-Day Total Return | -1.40% | |||
| 60-Day Total Return | 0.47% | |||
| 90-Day Total Return | -1.40% | |||
| Year to Date Total Return | 5.39% | |||
| 1-Year Total Return | 7.32% | |||
| 2-Year Total Return | 16.98% | |||
| 3-Year Total Return | 36.93% | |||
| 5-Year Total Return | 21.64% | |||
| Price | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | -- | |||
| 1-Month Low NAV | $12.59 | |||
| 1-Month High NAV | $12.89 | |||
| 52-Week Low NAV | $12.20 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $13.14 | |||
| 52-Week High Price (Date) | May 06, 2026 | |||
| Beta / Standard Deviation | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.19 | |||
| Standard Deviation | 7.99 | |||
| Balance Sheet | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.02B | |||
| Operating Ratios | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.79% | |||
| Turnover Ratio | 17.00% | |||
| Performance | FDAFX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 16.01% | |||
| Last Bear Market Total Return | -10.81% | |||